Sequoia Financial Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.83M Buy
35,328
+1,948
+6% +$161K 0.02% 478
2025
Q4
$2.85M Buy
33,380
+3,143
+10% +$258K 0.02% 468
2025
Q3
$2.35M Buy
30,237
+3,776
+14% +$295K 0.01% 473
2025
Q2
$2.07M Buy
26,461
+2,966
+13% +$221K 0.01% 461
2025
Q1
$1.7M Buy
23,495
+15,417
+191% +$1.1M 0.01% 474
2024
Q4
$598K Buy
8,078
+1,176
+17% +$82.3K 0.01% 744
2024
Q3
$455K Sell
6,902
-1,949
-22% -$142K ﹤0.01% 788
2024
Q2
$818K Sell
8,851
-2,695
-23% -$239K 0.01% 538
2024
Q1
$1.1M Sell
11,546
-2,212
-16% -$186K 0.01% 450
2023
Q4
$1.05M Buy
13,758
+4,095
+42% +$285K 0.01% 513
2023
Q3
$669K Sell
9,663
-3,700
-28% -$297K 0.01% 431
2023
Q2
$1.26M Sell
13,363
-1,400
-9% -$122K 0.02% 309
2023
Q1
$1.22M Buy
14,763
+1,340
+10% +$105K 0.03% 280
2022
Q4
$1M Buy
13,423
+5,247
+64% +$404K 0.02% 291
2022
Q3
$676K Sell
8,176
-481
-6% -$46.3K 0.02% 248
2022
Q2
$823K Sell
8,657
-524
-6% -$54.2K 0.02% 251
2022
Q1
$1.08M Buy
9,181
+941
+11% +$106K 0.03% 249
2021
Q4
$1.07M Buy
+8,240
New +$961K 0.03% 234
2021
Q3
Sell
-7,694
Closed -$797K 320
2021
Q2
$797K Buy
7,694
+957
+14% +$90.2K 0.03% 223
2021
Q1
$563K Buy
6,737
+357
+6% +$30.2K 0.02% 246
2020
Q4
$582K Buy
6,380
+6
+0.1% +$498 0.03% 229
2020
Q3
$509K Sell
6,374
-96
-1% -$7.49K 0.03% 223
2020
Q2
$447K Sell
6,470
-115
-2% -$8.17K 0.03% 231
2020
Q1
$414K Sell
6,585
-48
-0.7% -$3.46K 0.03% 218
2019
Q4
$516K Buy
6,633
+429
+7% +$33.5K 0.03% 214
2019
Q3
$455K Buy
6,204
+294
+5% +$20.7K 0.03% 206
2019
Q2
$364K Buy
5,910
+1,734
+42% +$105K 0.03% 250
2019
Q1
$266K Buy
+4,176
New +$238K 0.02% 293

Other funds holding EW